Earlier this year, the FDA approved BeiGene's Tevimbra as monotherapy for unresectable or metastatic esophageal squamous cell carcinoma. The focus will be on whether these approvals should be ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results